American Osteopathic Academy of Addiction Medicine - AOAAM

American Osteopathic Academy of Addiction Medicine - AOAAM Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from American Osteopathic Academy of Addiction Medicine - AOAAM, Addiction Resources Center, 1018 W Madison Stree, Suite 9, Chicago, IL.

American Osteopathic Academy of Addiction Medicine (AOAAM) represents osteopathic physicians involved in the treatment of alcoholism and substance use disorder.
--
https://aoaam.start.page

Worried About Nights, Weekends, and Wait Times? Try Tablets, Peers, & Parking LotsPresented by: Rachel Winograd, PhDLice...
01/12/2026

Worried About Nights, Weekends, and Wait Times? Try Tablets, Peers, & Parking Lots

Presented by: Rachel Winograd, PhD
Licensed Clinical Psychologist, Associate Professor, and Director of Addiction Science
University of Missouri–St. Louis

As overdose risk continues to be driven by fentanyl exposure, gaps in timely access to care remain a critical challenge—particularly outside traditional clinical settings.

This on-demand ORN Fall 2025 session explores:
🔹 How nontraditional access points can reduce barriers to evidence-based treatment
🔹 The role of peer support, low-threshold care, and mobile strategies in overdose prevention
🔹 Practical harm reduction approaches that support engagement, continuity, and person-centered care
🔹 Systems-level implications for expanding treatment access in real-world community settings

Dr. Winograd draws on research and implementation experience from the ASPIRE Lab and federally supported initiatives to highlight scalable strategies that improve overdose prevention, community health, and recovery outcomes.

Participants may earn CME/CNE credit upon completion.

Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from
. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Here's the link to the course: https://education.aoaam.org/URL/ORN2025-10-29

We’ve Redesigned the AOAAM Experience! The AOAAM website just got a fresh new look making it easier than ever to learn, ...
01/02/2026

We’ve Redesigned the AOAAM Experience!

The AOAAM website just got a fresh new look making it easier than ever to learn, connect, and advance in addiction medicine. From board certification review courses and CME opportunities to membership resources and upcoming events, everything you need is now just a click away.

🤖 New Feature Alert: Meet our AI chatbot—your on-demand guide for training, membership, and getting started. Have a question? The answers are now instant.

NAV & Associates is proud to support AOAAM as its association management partner in the launch of the newly redesigned website—delivering a more modern, intuitive experience with streamlined access to education, certification resources, and a new AI chat assistant that supports AOAAM’s commitment to innovation and member engagement.

Explore the new design, discover smarter navigation, and see how AOAAM is continuing to innovate for our community.

👉 Visit the new site today and experience it for yourself!
https://aoaam.com/

Joy and grief. Gratitude and fatigue. Hope and heaviness.All of it can exist at the same time.If your feelings feel comp...
12/16/2025

Joy and grief. Gratitude and fatigue. Hope and heaviness.
All of it can exist at the same time.

If your feelings feel complicated right now, you’re not alone and nothing is wrong with you.

At AOAAM, we believe acknowledging the human side of medicine is part of practicing it well.

🤖 The Role of Artificial Intelligence in Addiction MedicineArtificial intelligence is transforming healthcare but its po...
12/15/2025

🤖 The Role of Artificial Intelligence in Addiction Medicine
Artificial intelligence is transforming healthcare but its potential in addiction medicine is only beginning to be realized.

From improving early detection of substance use disorders to personalizing treatment plans and supporting long-term recovery, AI offers powerful opportunities to strengthen prevention, treatment, and recovery support. At the same time, important research gaps remain around ethics, data privacy, effectiveness, and real-world implementation.

A new article in the Journal of Addictive Diseases calls for a focused research agenda to responsibly harness AI highlighting both its promise and its limitations in addiction care.

👉 View the full article here: https://www.aoaam.org/general-news

💡 NAV & Associates is proud to support the mission of advancing innovation, research, and evidence-based solutions that improve addiction care and recovery outcomes nationwide.

Let’s continue the conversation:
How do you see AI shaping the future of behavioral health and addiction medicine?

Couldn't Attend OMED?Want to Revisit a Presentation?OMED25 is on demand through Dec. 31, 2025.Click this link to registe...
12/01/2025

Couldn't Attend OMED?

Want to Revisit a Presentation?

OMED25 is on demand through Dec. 31, 2025.

Click this link to register:

https://buff.ly/pAdF4Xj


_____

“Innovations in Clinical Practice: Managing Medetomidine Intoxication and Withdrawal in Philadelphia”Presented by: TaRev...
12/01/2025

“Innovations in Clinical Practice: Managing Medetomidine Intoxication and Withdrawal in Philadelphia”
Presented by: TaReva Warrick-Stone, DO
In late 2024, Philadelphia clinicians observed a significant shift in the unregulated drug supply: medetomidine an alpha-2 agonist and veterinary sedative rapidly overtook xylazine as the most common cutting agent found in fentanyl samples. This lecture examines the rise of this emerging substance, the evolving clinical challenges it presents, and evidence-informed strategies for managing its severe intoxication and withdrawal syndromes.

Learning Objectives:
By the end of this session, participants will be able to outline the emergence of medetomidine in Philadelphia’s street drug supply, recognize the clinical presentation of patients exposed to medetomidine from intoxication through withdrawal, and identify appropriate pharmacologic approaches for treating alpha-2 withdrawal.

Earn 1 AOA Category 1-A CME credit.

NAV & Associates remains committed to advancing addiction science and supporting efforts that improve care and outcomes for patients and the communities they belong to.

“Opioid Use Disorder, A View From the Other Side”Presented by: Keith Radbill, DOThis presentation highlights the importa...
11/24/2025

“Opioid Use Disorder, A View From the Other Side”
Presented by: Keith Radbill, DO

This presentation highlights the importance of medication-assisted treatment (MAT) and the often-overlooked challenges of Post Acute Withdrawal Syndrome (PAWS). Dr. Radbill shares his personal journey toward recovery, offering a powerful perspective to help those not directly affected by substance use disorder better understand what patients experience. Through this lived experience, the session emphasizes empathy, patient-centered care, and the emotional and physiological realities of sustaining sobriety.

Learning Objectives:
By the end of this presentation, participants will understand the impact of Post Acute Withdrawal Syndrome on sobriety, apply insights to better recognize the subjective suffering patients face, and utilize this knowledge to more effectively and compassionately deliver MAT for opioid use disorder.

This webinar has been approved for a maximum of 1 AOA Category 1-A CME credit.

NAV & Associates is honored to champion efforts that strengthen addiction science and support initiatives aimed at improving outcomes for patients and the communities we serve.

“Meeting Patients Where They Are: Navigating Decision-Making Challenges During Office-Based Management of Opioid Use Dis...
11/17/2025

“Meeting Patients Where They Are: Navigating Decision-Making Challenges During Office-Based Management of Opioid Use Disorder”

Presented by: Aaron Newcomb, DO

Buprenorphine treatment is evidence-based and lifesaving, yet clinicians regularly face complex scenarios that fall outside the scope of national guidelines and existing research. This presentation highlights common dilemmas in office-based opioid use disorder treatment and offers practical, patient-centered strategies for navigating uncertainty. Through real-world case examples, it explores decision-making around buprenorphine mono-product use, early refill requests, unexpected toxicology results, anonymous reports, and the co-prescribing of benzodiazepines or psychostimulants all while balancing compassionate care with regulatory considerations.

By the end of this session, participants will be able to recognize common clinical challenges in buprenorphine treatment that lack clear evidence or guidance, apply patient-centered and evidence-informed reasoning to ambiguous situations, understand how regulatory fears influence provider decision-making, and strengthen clinical judgment through case-based examples demonstrating nuanced, real-world approaches to care.

NAV & Associates is proud to support research and initiatives that advance addiction science and promote better outcomes for patients and communities.

American Osteopathic Academy of Addiction Medicine - AOAAM and Opioid Response Network Fall 2025 Presentation“Examining ...
11/06/2025

American Osteopathic Academy of Addiction Medicine - AOAAM and Opioid Response Network Fall 2025 Presentation

“Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-experimental Comparison”

Presented by: Anjalee Sharma, PhD
Assistant Research Scientist at Friends Research Institute, Baltimore, MD

As illicitly manufactured fentanyl has largely replaced he**in in the U.S., its withdrawal characteristics remain insufficiently understood.

This study investigates:
🔹 Comparative severity and progression of fentanyl-specific withdrawal
🔹 Self-reported vs. observed symptoms across two participant cohorts
🔹 Implications for clinical management and treatment strategies in the era of widespread fentanyl use

Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

NAV & Associates is proud to support research and initiatives that advance addiction science and promote better outcomes for patients and communities.

Couldn't Attend OMED?Want to Revisit a Presentation?OMED25 is on demand through Dec. 31, 2025.Click this link to registe...
11/01/2025

Couldn't Attend OMED?

Want to Revisit a Presentation?

OMED25 is on demand through Dec. 31, 2025.

Click this link to register:
https://buff.ly/qjgyzYk


_____

✨ Ready to make an impact in Addiction Medicine? ✨Whether you’re a practicing clinician, researcher, nurse, or student—m...
10/29/2025

✨ Ready to make an impact in Addiction Medicine? ✨

Whether you’re a practicing clinician, researcher, nurse, or student—membership in the American Osteopathic Academy of Addiction Medicine (AOAAM) connects you with a nationwide community dedicated to advancing prevention, treatment, and recovery.

Join a network of professionals committed to improving lives through education, collaboration, and leadership in addiction medicine. With multiple membership levels, AOAAM offers opportunities for every stage of your professional journey.

NAV & Associates takes pride in supporting AOAAM’s programs and memberships that empower and strengthen this vital medical community.

💡 Membership Tiers:
• Physicians – $250/year or $600/3 years
• PAs/Nurses – $125/year or $300/3 years
• Associates – $250/year or $600/3 years
• Residents (PGY1–4) & Medical Students – Free

👉 Discover your membership path today: https://www.aoaam.org/JoinAOAAM

Address

1018 W Madison Stree, Suite 9
Chicago, IL
60607

Website

https://aoaam.org/

Alerts

Be the first to know and let us send you an email when American Osteopathic Academy of Addiction Medicine - AOAAM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to American Osteopathic Academy of Addiction Medicine - AOAAM:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram